Functional Improvement with Hylan G-F 20 in Patients with Knee Osteoarthritis

References

• . Creamer P, Lethbridge-Cejku M, Hochberg MC. Factors associated with functional impairment in symptomatic knee osteoarthritis. Rheumatology (Oxford). 2000;39(5):490–496
   PubMed Web of Science ®Google Scholar
• . Verbrugge LM, Juarez L. Profile of arthritis disability: II. Arthritis Rheum. 2006;55(1):102–113
   PubMed Web of Science ®Google Scholar
• . Hootman JM, Helmick CG, Schappert SM. Magnitude and characteristics of arthritis and other rheumatic conditions on ambulatory medical care visits, United States, 1997. Arthritis Rheum. 2002;47(6):571–581
   PubMedGoogle Scholar
• . Williams FM, Spector TD. Osteoarthritis. Medicine. 2006;34(9):364–368
   Google Scholar
• . Spector TD, Harris PA, Hart DJ, . Risk of osteoarthritis associated with long-term weight-bearing sports: a radiologic survey of the hips and knees in female ex-athletes and population controls. Arthritis Rheum. 1996;39(6):988–995
   PubMed Web of Science ®Google Scholar
• . Caborn D, Rush J, Lanzer W, Parenti D, Murray C; Synvisc 901 Study Group. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31(2):333–343
   PubMed Web of Science ®Google Scholar
• . Raynauld JP, Torrance GW, Band PA, . A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage. 2002;10(7):506–517
   PubMed Web of Science ®Google Scholar
• . Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther. 1998;20(3):410–423
   PubMed Web of Science ®Google Scholar
• . Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res. 1994;55(3):220–232
   Web of Science ®Google Scholar
• . Adams ME, Atkinson MH, Lussier AJ, . The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage. 1995;3(4):213–225
   PubMed Web of Science ®Google Scholar
• . Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Médicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol. 1996;23(9):1579–1585
   PubMed Web of Science ®Google Scholar
• . Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int. 1987;7(3):113–122
   PubMed Web of Science ®Google Scholar
• . Bagga H, Burkhardt D, Sambrook P, March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33(5):946–950
   PubMed Web of Science ®Google Scholar
• . Karatosun V, Unver B, Gocen Z, Sen A, Gunal I. Intra-articular hyaluronic acid is compared with progressive knee exercises in osteoarthritis of the knee: a prospective randomized trial with long-term follow-up. Rheumatol Int. 2006;26(4):277–284
   PubMed Web of Science ®Google Scholar
• . Kahan A, Lleu PL, Salin L. Prospective randomized study comparing the medico-economic benefits of hylan GF-20 vs conventional treatment in knee osteoarthritis. Joint Bone Spine. 2003;70(4):276–281
   PubMed Web of Science ®Google Scholar
• . Dickson DJ, Hosie G, English JR. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res. 2001;4:41–52
   Google Scholar
• . Karlsson J, Sjögren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford). 2002;41(11):1240–1248
   PubMed Web of Science ®Google Scholar
• . Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–1840
   PubMed Web of Science ®Google Scholar
• . McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001;45(5):453–461
   PubMed Web of Science ®Google Scholar
• . Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–1840
   PubMed Web of Science ®Google Scholar
• . Bellamy N, Campbell J, Stevens J, Pilch L, Stewart C, Mahmood Z. Validation study of a computerized version of the Western Ontario McMaster Universities VA3.0 Osteoarthritis Index. J Rheumatol. 1997;24(12):2413–2415
   PubMed Web of Science ®Google Scholar
• . Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol. 1997;50(3):239–246
   PubMed Web of Science ®Google Scholar
• . Stucki G, Sangha O, Stucki S, . Comparison of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis. Osteoarthritis Cartilage. 1998;6(2):79–86
   PubMed Web of Science ®Google Scholar
• . Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483
   PubMed Web of Science ®Google Scholar
• . Ware JE Jr. SF-36 health survey update. Spine (Phila PA 1976). 2000;25(24):3130–3139
   PubMed Web of Science ®Google Scholar
• . Kosinski M, Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care. 1999;37( 5 suppl):MS23–MS39
   PubMed Web of Science ®Google Scholar
• . Ware JE, Snow KK, Kosinski M. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute; 1997
   Google Scholar
• . Anderson JG, Wixson RL, Tsai D, Stulberg SD, Chang RW. Functional outcome and patient satisfaction in total knee patients over the age of 75. J Arthroplasty. 1996;11(7):831–840
   PubMed Web of Science ®Google Scholar
• . Alicea J. Scoring systems and their validation for the arthritic knee. In: Insall JN, Scott WN, eds. Surgery of the knee. Philadelphia, PA: Churchill Livingstone; 2001:1507–1515
   Google Scholar
• . Gore DR, Murray MP, Sepic SB, Gardner GM. Correlations between objective measures of function and a clinical knee rating scale following total knee replacement. Orthopedics. 1986;9(10):1363–1367
   PubMed Web of Science ®Google Scholar
• . Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation—value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987;65:85–89
   PubMedGoogle Scholar
• . Bellamy N, Campbell J, Hill J, Band P. A comparative study of telephone versus onsite completion of the WOMAC 3.0 osteoarthritis index. J Rheumatol. 2002;29(4):783–786
   PubMed Web of Science ®Google Scholar
• . Penninx BW, Messier SP, Rejeski WJ, . Physical exercise and the prevention of disability in activities of daily living in older persons with osteoarthritis. Arch Intern Med. 2001;161(19):2309–2316
   PubMed Web of Science ®Google Scholar
• . Van Baar ME, Assendelft WJ, Dekker J, Oostendorp RA, Bijlsma JW. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum. 1999;42(7):1361–1369
   PubMed Web of Science ®Google Scholar
• . Thomas KS, Muir KR, Doherty M, Jones AC, O'Reilly SC, Bassey EJ. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ. 2002;325(7367):752
   PubMed Web of Science ®Google Scholar
• . Devos-Comby L, Cronan T, Roesch SC. Do exercise and self-management interventions benefit patients with osteoarthritis of the knee? A metaanalytic review. J Rheumatol. 2006;33(4):744–756
   PubMed Web of Science ®Google Scholar
• . Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999;11(5):417–421
   PubMedGoogle Scholar
• . Moskowitz RW, Davis W, Sammarco J, Mast W, Chase SW. Experimentally induced corticosteroid arthropathy. Arthritis Rheum. 1970;13(3):236–243
   PubMedGoogle Scholar
• . Stitik TP, Blacksin MF, Stiskal DM, . Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain. Arch Phys Med Rehabil. 2007;88(2):135–141
   PubMed Web of Science ®Google Scholar
• . Goorman SD, Watanabe TK, Miller EH, Perry C. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study. Arch Phys Med Rehabil. 2000;81(4):479–483
   PubMed Web of Science ®Google Scholar
• . Tetik S, Ones K, Tetik C. Efficacy of intra-articular hylan G-F 20 on osteoarthritis of the knee. Pain Clinic. 2003;15(4):459–466
   Web of Science ®Google Scholar
• . Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomized controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int. 2006;26(4):325–330
   PubMed Web of Science ®Google Scholar
• . Lee S, Park D, Chmell SJ. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients. J Knee Surg. 2004;17(2):73–77
   PubMedGoogle Scholar
• . Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002;162(3):292–298
   PubMedGoogle Scholar
• . Atamaz F, Kirazli Y, Akkoc Y. A comparison of two different intra-articular hyaluronan drugs and physical therapy in the management of knee osteoarthritis. Rheumatol Int. 2006;26(10):873–878
   PubMed Web of Science ®Google Scholar
• . Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19(1):19–27
   PubMedGoogle Scholar
• . Brander VA, Stulberg SD, Adams AD, . Predicting total knee replacement pain: a prospective, observational study. Clin Orthop Relat Res. 2003;416:27–36
   PubMed Web of Science ®Google Scholar